Venus Remedies Limited
VENUSREM.NS
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.95B
Close$
$949.94
41.4% downside
Current Fair Value
41.4% downsideOvervalued by 41.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $21.95 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $10.00 (0.62%) |
| Earnings per Share | $76.89 |
| Beta | 0.35 |
| Outstanding Shares | 13,366,988 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | 18.53 |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Venus Remedies Limited
1,472 employees
CEO: Ashutosh Jain Founded in 1989 and based in Panchkula, India, Venus Remedies Limited is engaged in the global development and commercialization of pharmaceutical products. The company's extensive portfolio encompasses a wide array of therapeutic catego...